NewGenIvf Group Limited Announces Reverse Stock Split

NewGenIvf Group Limited is implementing a reverse stock split of its issued and unissued shares at a ratio of one (1) share for every four (4) shares. This action, approved by the Board of Directors on February 13, 2026, will be effective at 12:01 a.m. (ET) on March 16, 2026. The Class A Ordinary Shares will commence trading on a split-adjusted basis on the Nasdaq Capital Market under the symbol "NIVF" on the same date, with a new CUSIP number G0544E147. The reverse stock split will reduce the number of outstanding Class A Ordinary Shares from 2,273,790 to approximately 568,323. Fractional shares will not be issued; instead, shareholders entitled to a fractional share will receive one full post-reverse stock split Class A Ordinary Share. All outstanding options, warrants, and convertible securities will also be adjusted proportionally. No shareholder approval is required for this reverse stock split.